OBJECTIVE: The present study reviewed voxel-based morphometry (VBM) studies on high-risk individuals with schizophrenia, patients experiencing their first-episode schizophrenia (FES), and those with chronic schizophrenia. We predicted that gray matter abnormalities would show progressive changes, with most extensive abnormalities in the chronic group relative to FES and least in the high-risk group. METHOD: Forty-one VBM studies were reviewed. Eight high-risk studies, 14 FES studies, and 19 chronic studies were analyzed using anatomical likelihood estimation meta-analysis. RESULTS: Less gray matter in the high-risk group relative to controls was observed in anterior cingulate regions, left amygdala, and right insula. Lower gray matter volumes in FES compared with controls were also found in the anterior cingulate and right insula but not the amygdala. Lower gray matter volumes in the chronic group were most extensive, incorporating similar regions to those found in FES and high-risk groups but extending to superior temporal gyri, thalamus, posterior cingulate, and parahippocampal gryus. Subtraction analysis revealed less frontotemporal, striatal, and cerebellar gray matter in FES than the high-risk group; the high-risk group had less gray matter in left subcallosal gyrus, left amygdala, and left inferior frontal gyrus compared with FES. Subtraction analysis confirmed lower gray matter volumes through ventral-dorsal anterior cingulate, right insula, left amygdala and thalamus in chronic schizophrenia relative to FES. CONCLUSIONS: Frontotemporal brain structural abnormalities are evident in nonpsychotic individuals at high risk of developing schizophrenia. The present meta-analysis indicates that these gray matter abnormalities become more extensive through first-episode and chronic illness. Thus, schizophrenia appears to be a progressive cortico-striato-thalamic loop disorder.
OBJECTIVE: The present study reviewed voxel-based morphometry (VBM) studies on high-risk individuals with schizophrenia, patients experiencing their first-episode schizophrenia (FES), and those with chronic schizophrenia. We predicted that gray matter abnormalities would show progressive changes, with most extensive abnormalities in the chronic group relative to FES and least in the high-risk group. METHOD: Forty-one VBM studies were reviewed. Eight high-risk studies, 14 FES studies, and 19 chronic studies were analyzed using anatomical likelihood estimation meta-analysis. RESULTS: Less gray matter in the high-risk group relative to controls was observed in anterior cingulate regions, left amygdala, and right insula. Lower gray matter volumes in FES compared with controls were also found in the anterior cingulate and right insula but not the amygdala. Lower gray matter volumes in the chronic group were most extensive, incorporating similar regions to those found in FES and high-risk groups but extending to superior temporal gyri, thalamus, posterior cingulate, and parahippocampal gryus. Subtraction analysis revealed less frontotemporal, striatal, and cerebellar gray matter in FES than the high-risk group; the high-risk group had less gray matter in left subcallosal gyrus, left amygdala, and left inferior frontal gyrus compared with FES. Subtraction analysis confirmed lower gray matter volumes through ventral-dorsal anterior cingulate, right insula, left amygdala and thalamus in chronic schizophrenia relative to FES. CONCLUSIONS: Frontotemporal brain structural abnormalities are evident in nonpsychotic individuals at high risk of developing schizophrenia. The present meta-analysis indicates that these gray matter abnormalities become more extensive through first-episode and chronic illness. Thus, schizophrenia appears to be a progressive cortico-striato-thalamic loop disorder.
Authors: Nicole R Giuliani; Vince D Calhoun; Godfrey D Pearlson; Alan Francis; Robert W Buchanan Journal: Schizophr Res Date: 2005-05-01 Impact factor: 4.939
Authors: E M Meisenzahl; N Koutsouleris; C Gaser; R Bottlender; G J E Schmitt; P McGuire; P Decker; B Burgermeister; C Born; Maximilian Reiser; H-J Möller Journal: Schizophr Res Date: 2008-04-25 Impact factor: 4.939
Authors: Andrew M McIntosh; Dominic E Job; William J Moorhead; Lesley K Harrison; Heather C Whalley; Eve C Johnstone; Stephen M Lawrie Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2006-01-05 Impact factor: 3.568
Authors: M H Chakos; J A Lieberman; R M Bilder; M Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; M Ashtari Journal: Am J Psychiatry Date: 1994-10 Impact factor: 18.112
Authors: H E Hulshoff Pol; H G Schnack; R C Mandl; N E van Haren; H Koning; D L Collins; A C Evans; R S Kahn Journal: Arch Gen Psychiatry Date: 2001-12
Authors: Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero Journal: Eur Neuropsychopharmacol Date: 2014-08-01 Impact factor: 4.600
Authors: Martin Rozycki; Theodore D Satterthwaite; Nikolaos Koutsouleris; Guray Erus; Jimit Doshi; Daniel H Wolf; Yong Fan; Raquel E Gur; Ruben C Gur; Eva M Meisenzahl; Chuanjun Zhuo; Hong Yin; Hao Yan; Weihua Yue; Dai Zhang; Christos Davatzikos Journal: Schizophr Bull Date: 2018-08-20 Impact factor: 9.306
Authors: Yi Wang; Chao Yan; Da-zhi Yin; Ming-xia Fan; Eric F C Cheung; Christos Pantelis; Raymond C K Chan Journal: Schizophr Bull Date: 2014-12-22 Impact factor: 9.306
Authors: Nathan L Hutcheson; David G Clark; Mark S Bolding; David M White; Adrienne C Lahti Journal: Psychiatry Res Date: 2013-10-22 Impact factor: 3.222